DURAVOL is not banned in sports. As a parts of the quality program of Eiselt, Duravol is analyzed for banned substances on a continuous basis. DURAVOL can be used by males and females over 21 years.

DURAVOL can be used to:

Enhance fat burning while maintaining or increasing lean body mass. Just cut down on calories, increate protein intake somewhat and do some cardio.

Gain lean mass. DURAVOL will allow you to eat more muscle building calories and keep fat deposition at a minimum.

DOSAGE:
Two capsules immediately before workout. On non-training days, consume 2 capsules before breakfast. Dosage may be increased to 3 capsules daily for athletes + 90 kg (198 lbs).

INGREDIENTS:
Torabolic [0,3 g per capsule (proprietary patent extract from Trigonella Foenum-Graecum seeds)], magnesium stearate, gelatine capsule.

US customers, please contact EP2, Inc.

 

DURAVOL is a non-androgenic "gym pill" working through an unique and safe method of action that helps improving body composition. This has been demonstrated in pre-clinical and clinical studies on human test subjects.

What to expect from DURAVOL:
1. Significant increase in fat loss
2. Significant increase in strength
3. Significant increase in lean body mass

DURAVOL is produced by Eiselt Research in Sweden under license of Indus Biotech, a drug discovery and development company based in India.

The active ingredient in Duravol, called Torabolic, is a highly purified molecule extracted and purified from the seeds of Fenugreek (Trigonella Foenum-Graecum). Torabolic is patented worldwide by Indus Biotech and can not be compared to other extracts of fenugreek.

The safety of DURAVOL (Torabolic) has been verified by acute toxicity tests, AMES-test, 90 day-repeated dos toxicity test as well as standard test during clinical trials (kidney function, lipid profiles, hormone profile, liver, hemodynamic and blood variables). Nothing indicates that Duravol/Torabolic would be harmful to your health.
 

 

 

 _______________________________________________________________________________________
 _____________________________________________________________________________________

 

EISELT RESEARCH | 449 11 NOL | SWEDEN | FAX +46 303 333 145
E-MAIL: INFO at EISELT.SE